Success Metrics

Active Trials
0(0%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A

Trials by Status

not_yet_recruiting150%
enrolling_by_invitation150%

Recent Activity

0 active trials
Showing 2 of 2
enrolling_by_invitation

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study (PUER) in Ages 6 Through 18

NCT06802029
not_yet_recruiting

Application of Transcriptome Sequencing Combined With Family-Based Whole Genome Sequencing in Improving Precise Diagnosis of Critically Ill Newborns in Northeast China

NCT06990334

Clinical Trials (2)

Showing 2 of 2 trials
NCT06802029

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study (PUER) in Ages 6 Through 18

Enrolling By Invitation
NCT06990334

Application of Transcriptome Sequencing Combined With Family-Based Whole Genome Sequencing in Improving Precise Diagnosis of Critically Ill Newborns in Northeast China

Not Yet Recruiting

All 2 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
2